Krsnaa Diagnostics Limited, established in 2010 and headquartered in Pune, India, provides comprehensive diagnostic services across the country, focusing on non-metro and lower-tier cities. The company offers a wide range of radiology and pathology services, including X-ray, CT Scan, MRI, Mammography, Tele-Reporting, and various blood and urine tests. Over the years, Krsnaa has significantly expanded its footprint, operating over 3,600 diagnostic centers across 13 states as of FY 2024, emphasizing public-private partnerships.
The company went public in August 2021, raising Rs. 1213.33 Crore through its IPO. Krsnaa Diagnostics has continuously enhanced its service offerings and infrastructure, including the operationalization of new radiology and pathology centers and a Teleradiology hub in Pune accredited by the NABH in 2023. This growth strategy positions Krsnaa as a leading provider of diagnostic services in India's underserved regions.
